滚动资讯
FierceBiotechIn another reversal for rare disease field, FDA to reconsider Regenxbio gene therapyEndpoints NewsMerck's IBD drug from $10.8B Prometheus deal claims its first Phase 3 winFierceBiotech默沙东收购Prometheus获得的抗TL1A抗体在溃疡性结肠炎III期试验中取得突破PharmaVoice辉瑞首席财务官离职转投消费品行业FierceBiotech赛诺菲与Pangaea签署AI合作协议，检测未被充分诊断的遗传疾病PharmaVoice赛诺菲与罗氏支持，Orano Med 追逐放射药物领导地位BioWorldBrightgene Bio-Medical Technology synthesizes new GIPR, GCGR and GLP-1R agonistsBioWorldTennor Therapeutics discovers new antibacterial agentsBioWorldAsahi Kasei Therapeutics reports new TNFR1 antagonistsBioWorldNLRP3 inflammasome inhibitors disclosed in Evotec patentBioWorldF2G准备提交20年来首个新型抗真菌药的III期临床数据，申请保密协议Labiotech生物制药领域最昂贵的8种药物：揭秘最贵药品

资讯库

最新 最旧 清除
@Agilent
总数 513
来源 Agilent
搜索 --